Could Sugary supports management of Be Behind the UK’s Bowel Cancer Crisis?

By Rebecca Padgett | Maternity Nurse and Gut Health Practitioner

There is something rather uncomfortable hiding in Britain’s kitchen cupboards. It is not a forgotten tin of baked beans or the mysterious jar at the back of the fridge. It is sugar.

Britain has a well-documented bowel cancer problem, and growing research is prompting scientists to look more closely at diet, body weight, inflammation, the gut microbiome and ultra-processed foods. But could sugary supports management of really be part of the picture?

The short answer is: possibly, but they are unlikely to be the whole story.

Bowel cancer is the UK’s fourth most common cancer, and NHS England says it has become more common in recent years. The NHS is now strengthening screening, with a lower threshold for its home FIT test expected to detect around 600 additional bowel cancers earlier each year in England.

So, could sugary supports management of and bowel cancer be connected? Increasingly, researchers think there may be several links worth paying attention to.

The sweet problem on our plates

A biscuit with a cup of tea is hardly a public-health emergency. Neither is the occasional slice of birthday cake. The concern is what happens when sweet foods and drinks become an everyday feature of the diet.

Sugary drinks, sweets, cakes, biscuits and many ultra-processed snacks can provide substantial calories without offering much fibre, protein or micronutrient value.

That matters because maintaining a healthy body weight is one of the established factors associated with cancer proactive support. The World Cancer Research Fund recommends limiting sugar-sweetened drinks and highly processed foods high in fat, starches or sugars.

And now there is more direct evidence.

A 2026 World Cancer Research Fund Global Cancer Update Programme review analysed 158 publications from 51 cohorts. For sugar-sweetened beverages, the researchers found a probable causal positive association with colorectal cancer incidence: each additional 355 ml serving per day was associated with a relative risk of 1.07 (95% CI 1.00–1.14), based on 13 studies.

That does not mean drinking a fizzy drink gives someone bowel cancer.

It means that, at population level, higher consumption was associated with a modestly higher risk, and the researchers judged the evidence strong enough to describe the relationship as probably causal.

That is an important distinction.

Could sugar affect the gut itself?

This is where the story becomes more interesting.

The gut is home to trillions of microorganisms that interact with our food, immune system and intestinal lining. Diet can influence this ecosystem, sometimes helping beneficial bacteria thrive and sometimes encouraging an imbalance.

A diet dominated by sugary, low-fibre foods may also crowd out foods that the gut tends to appreciate: vegetables, fruit, pulses, wholegrains, nuts and seeds.

Think of the microbiome as a garden. It is difficult to grow a magnificent botanical garden if all you do is sprinkle it with sweets.

Dietary fibre, on the other hand, provides material that gut bacteria can ferment into compounds such as short-chain fatty acids. These compounds are involved in maintaining the intestinal environment and communicating with cells in the gut and immune system.

This does not prove that sugar directly causes bowel cancer. In fact, the WCRF has previously concluded that evidence for sugar itself, as distinct from broader dietary patterns and sugary drinks, was not strong enough to establish a clear independent relationship with colon cancer risk.

The bigger picture therefore matters: excess calories, obesity, low fibre intake, processed foods, physical inactivity and metabolic health can overlap.

The inflammation connection

Inflammation is another piece of the puzzle.

Chronic inflammation can affect tissues over long periods, and inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis are recognised risk factors for bowel cancer. The NHS also lists being overweight and having inflammatory bowel disease among factors associated with increased risk.

This has led to growing interest in whether supporting a healthier gut environment might be useful as part of a wider healthy lifestyle.

However, it is important not to oversell the science. A supplement cannot be described as a management approaches for bowel cancer, nor can it replace medical assessment, screening or a balanced diet.

Could restoring gut health help?

One approach attracting attention is combining probiotic support with prebiotic fibre.

Maxilin Super Probiotic, for example, is marketed as a synbiotic-style product containing probiotic microorganisms alongside prebiotic ingredients. Product information describes three probiotic strains — Lactobacillus acidophilus, Streptococcus thermophilus and Lactobacillus helveticus — together with inulin and resistant dextrin.

The idea behind this type of formulation is relatively straightforward: provide beneficial microorganisms while also providing fibre that can support microbial activity.

Could Maxilin and L-Arginine play a role in supporting gut health?

Potentially, but the evidence needs careful interpretation.

Research into L-arginine is particularly interesting because arginine is involved in nitric oxide production, immune function and tissue biology.

In a small human study involving eight healthy volunteers, researchers examined the effects of arginine on human intestinal tissue. Arginine increased nitric oxide production under inflammatory conditions, but it did not significantly change the production of the inflammatory cytokines IL-6 and IL-8 or the anti-inflammatory cytokines IL-4 and IL-10. The researchers concluded that further clinical research was needed.

There is also encouraging experimental evidence. A 2026 study found that dietary L-arginine supplementation reduced markers associated with intestinal barrier dysfunction and inflammation in a mouse model of colitis, while also altering the gut microbiota. However, animal findings cannot automatically be translated into benefits for people.

Earlier animal research similarly found that L-arginine supplementation tended to reduce intestinal permeability and preserve the intestinal mucosa during experimentally induced colitis.

So, while Maxilin and L-Arginine may be interesting components of a gut-health strategy, there is currently insufficient clinical evidence to say that the combination supports defence against bowel cancer or supports management of intestinal inflammation in humans.

What about Maxilin?

The evidence for probiotics is complicated because “probiotic” is not a single management approaches. Different strains can behave differently, and evidence for one strain cannot automatically be applied to another.

Maxilin's own information describes it as a food supplement rather than a medicine and explicitly states that it is not intended to diagnose, treat, cure or prevent disease.

That is an important caveat.

A sensible approach is to see Maxilin for gut health as potentially one part of a broader routine rather than a magic reset button. Food quality, fibre intake, exercise, sleep, alcohol consumption, smoking, body weight and medication use can all influence health.

So, are sugary supports management of causing Britain’s bowel cancer crisis?

Probably not on their own.

But there is a growing argument that our modern food environment deserves much more attention.

The latest evidence linking sugar-sweetened drinks with colorectal cancer adds to a broader picture in which excess body weight, poor diet and low-quality food patterns may contribute to cancer risk.

Meanwhile, research into the microbiome and intestinal inflammation is giving scientists a better understanding of how diet might influence the environment in which bowel disease develops.

The answer is therefore less “ban the biscuit” and more “look at the whole diet”.

A healthier pattern would mean plenty of fibre-rich plant foods, wholegrains, vegetables, fruit, pulses, nuts and seeds; fewer sugary drinks and highly processed snacks; sensible alcohol consumption; regular movement; and maintaining a healthy weight.

And yes, there can still be room for the occasional biscuit. Life without cake would be a grim experiment.

The most important bowel-health message

There is one thing that matters more than any supplement, superfood or dietary theory: do not ignore symptoms.

The NHS advises speaking to a GP if bowel symptoms persist for three weeks or more. Warning signs can include blood in the poo, a persistent change in bowel habits, unexplained weight loss, abdominal pain, bloating or unusual tiredness.

If you are offered bowel cancer screening, do it.

The NHS reports that around 100 bowel cancers a week were detected through its screening programme during 2024/25, while almost 5.2 million people took part.

Ultimately, sugary supports management of and bowel cancer may be connected through a complicated web of diet, metabolic health, inflammation and the microbiome. But there is no single culprit sitting in the biscuit tin.

The better strategy is to protect the gut from several directions at once: eat more plants and fibre, reduce sugary drinks and heavily processed foods, stay active, maintain a healthy weight, take screening seriously and seek medical advice when something does not feel right.

And if you are considering Maxilin and L-Arginine, think of them as potential nutritional additions to that bigger picture — not substitutes for proper medical care.

References and clinical research

1. World Cancer Research Fund International Global Cancer Update Programme. Sugar sweetened and artificially sweetened beverages, fruit and vegetable juices and cancer risk. 2026.

2. World Cancer Research Fund/AICR. Evidence on diet, nutrition, physical activity and colorectal cancer.

3. World Cancer Research Fund International. Limit sugar-sweetened drinks.

4. NHS England. NHS to detect and prevent thousands more bowel cancers with more sensitive screening. 26 January 2026.

5. NHS England. NHS detects tens of thousands of bowel cancers thanks to screening programme. 20 April 2026.

6. NHS England. NHS urges people in their 50s to return bowel screening kits as 100 cancers found a week. 11 July 2026.

7. Modulation of nitric oxide and cytokines production by L-arginine in human gut mucosa. PubMed, PMID 15896421.

8. Andrade ME et al. Pretreatment and management approaches With L-Arginine Attenuate Weight Loss and Bacterial Translocation in Dextran Sulfate Sodium Colitis. JPEN, 2016.

9. Gong et al. Dietary L-arginine supplementation exerts preventive effects on colitis through modulation of the gut microbiota. 2026.

Your Longevity Journey Begins Here !